BlackRock
PRAX icon

BlackRock’s Praxis Precision Medicines PRAX Stock Holding History

BlackRock’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$768M Sell
2,292,585
-32,344
-1% -$10.2M 0.01% 913
2026
Q1 		$749M Buy
2,324,929
+246,429
+12% +$76.2M 0.01% 844
2025
Q4 		$613M Buy
2,078,500
+277,420
+15% +$51.7M 0.01% 976
2025
Q3 		$95.5M Buy
1,801,080
+210,952
+13% +$10.2M ﹤0.01% 2126
2025
Q2 		$66.9M Buy
1,590,128
+173,193
+12% +$6.6M ﹤0.01% 2286
2025
Q1 		$53.7M Sell
1,416,935
-45,510
-3% -$2.84M ﹤0.01% 2342
2024
Q4 		$113M Buy
1,462,445
+160,010
+12% +$11.6M ﹤0.01% 2008
2024
Q3 		$74.9M Buy
1,302,435
+8,435
+0.7% +$456K ﹤0.01% 2244
2024
Q2 		$53.5M Buy
1,294,000
+1,072,255
+484% +$50.7M ﹤0.01% 2369
2024
Q1 		$13.5M Buy
221,745
+95,209
+75% +$4.27M ﹤0.01% 3189
2023
Q4 		$2.82M Buy
126,536
+1,546
+1% +$27.8K ﹤0.01% 3905
2023
Q3 		$3.21M Buy
124,990
+84,728
+210% +$1.6M ﹤0.01% 3841
2023
Q2 		$695K Sell
40,262
-152,290
-79% -$2.33M ﹤0.01% 4392
2023
Q1 		$2.34M Sell
192,552
-5,565
-3% -$235K ﹤0.01% 3982
2022
Q4 		$7.07M Sell
198,117
-18,163
-8% -$566K ﹤0.01% 3555
2022
Q3 		$7.37M Buy
216,280
+18,229
+9% +$908K ﹤0.01% 3586
2022
Q2 		$7.28M Buy
198,051
+29,400
+17% +$3.14M ﹤0.01% 3657
2022
Q1 		$25.8M Buy
168,651
+2,205
+1% +$453K ﹤0.01% 3004
2021
Q4 		$49.2M Buy
166,446
+23,468
+16% +$6.88M ﹤0.01% 2673
2021
Q3 		$39.7M Buy
142,978
+42,046
+42% +$11.4M ﹤0.01% 2814
2021
Q2 		$27.7M Buy
100,932
+20,395
+25% +$7.3M ﹤0.01% 3103
2021
Q1 		$39.6M Buy
80,537
+711
+0.9% +$506K ﹤0.01% 2782
2020
Q4 		$65.9M Buy
+79,826
New +$46.6M ﹤0.01% 2309

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BlackRock's PRAX Position: Q2 2026 in Review

BlackRock reduced its Praxis Precision Medicines (PRAX) stake by 1.4% in Q2 2026, selling an estimated $10.2M and leaving 2,292,585 shares worth $768M. The position accounts for 0.01% of the portfolio, ranked #913.

BlackRock first reported a position in PRAX in Q4 2020 and has held it in 23 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • BlackRock held 2,292,585 shares of Praxis Precision Medicines worth $768M as of Q2 2026.
  • BlackRock sold 32,344 Praxis Precision Medicines shares in Q2 2026, an estimated $10.2M.
  • Praxis Precision Medicines made up 0.01% of BlackRock's portfolio in Q2 2026, its #913 holding.
  • BlackRock first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 23 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.